BioDiscovery
- Company typePublic
- Founded1997
- HeadquartersAnn Arbor, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
BioDiscovery firmographics
Firmographics- Name
- BioDiscovery
- Legal name
- Bionano Genomics, Inc.
- Website
- https://biodiscovery.com
- Company type
- Public
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
BioDiscovery industry classification
Industry- Product category
- Genomic Analysis Software
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Medical Laboratories (621511)
- SIC
- Laboratory Analytical Instruments (3826), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
- akta.pro secondary industries
- Bioinformatics & Multi-omics Analysis Software (HLAGAJAD), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL)
Keywords
Where BioDiscovery is headquartered
LocationHeadquarters
- HQ city
- Ann Arbor
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
BioDiscovery business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- OGM Hardware Systems: Sale of optical genome mapping instruments including Stratys System and Saphyr System for genomic analysis. These are high-value capital equipment purchases for research and clinical laboratories.
- Software Licenses and Subscriptions: Revenue from VIA software, Access software, and analysis solutions. Software provides data interpretation, integration with NGS and microarray data, and ongoing analysis capabilities.
- Consumables and Kits: Recurring revenue from sample preparation kits, Ionic purification kits with G2 chemistry, and other consumables required for OGM workflows.
- Data Services: OGM data services offered through Bionano Laboratories and Certified Service Providers for customers who prefer outsourced analysis rather than in-house processing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise/Institutional Pricing |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
BioDiscovery product offering
Product offeringCore offering
BioDiscovery develops scientific software and instrumentation for genetic research and genomic analysis. The company's portfolio includes optical genome mapping systems (Stratys, Saphyr) for structural variant detection, analysis software (VIA, Access, EnFocus) for integrating OGM, NGS, and microarray data, the Ionic nucleic acid purification system using isotachophoresis, and consumables and data services supporting end-to-end genomic workflows.
Product overview
Bionano offers a platform-plus-modules architecture centered on optical genome mapping (OGM) technology. The core systems include the Stratys™ System and Saphyr® System for genome-wide structural variant detection, supported by VIA™ Software and Access Software for data analysis and interpretation. Sample preparation and purification is handled through the Ionic® System and associated kits. The portfolio integrates Compute Solutions for data processing and EnFocus Analysis for focused examination. Bionano Laboratories and its network of Certified Service Providers offer data services and OGM expertise, creating an end-to-end solution from sample preparation through comprehensive genomic analysis.
Differentiator
Problem solved
Functional benefit
Products and services
- Stratys™ System Optical genome mapping system that reveals all classes of structural variants using digital precision in a rapid, highly automated workflow from sample preparation through primary data analysis. Designed for clinical and research laboratories.
- Saphyr® System Genome-wide detection and analysis platform for all classes of structural variants from ultra-high molecular weight DNA using optical genome mapping technology. Designed for research and clinical genomics laboratories.
- VIA™ Software Analysis software that receives and interprets data from optical genome mapping (OGM), next-generation sequencing (NGS) and microarrays to contextualize all classes of genomic variation in one view for comprehensive interpretation.
- Access Software Software product for data access and management in the genomic analysis workflow.
- Ionic® System Purification system that uses isotachophoresis (ITP) to isolate, purify, and concentrate genomic DNA and RNA from cells, tissue, and FFPE samples with Ionic G2 chemistry. Requires minimal hands-on time per sample.
- Ionic® Purification Kits Purification kits for use with the Ionic System, enabling DNA and RNA sample preparation with minimal hands-on time per sample.
- Sample Preparation Kits Kits for preparing samples for optical genome mapping analysis.
- Compute Solutions Computing infrastructure and solutions for processing optical genome mapping data at scale.
- EnFocus Analysis Analysis tool for focused examination of genomic data in optical genome mapping workflows.
- OGM Data Services Data services offering for optical genome mapping analysis provided by Bionano Laboratories and a network of Certified Service Providers, for customers who prefer outsourced analysis rather than in-house processing.
Quantifiable outcome
- Over 500 publications cite OGM solutions demonstrating scientific validation
Companies that use BioDiscovery
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles2 records
BioDiscovery technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
BioDiscovery partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and flagship.
- RevvitycoreBionano announced a software marketing agreement with Revvity for newborn sequencing research. Revvity, a company focused on reproductive and prenatal health, will market Bionano's software solutions in connection with newborn sequencing research initiatives.
- DiagensflagshipBionano and Diagens signed a partnership to commercialize the first ever clinical cytogenetic analysis that combines OGM and Artificial Intelligence. This strategic partnership integrates Diagens' AI capabilities with Bionano's OGM technology to advance clinical cytogenetics applications.
Scale indicators2 records
Recent moves5 records
Expansion highlights5 records
BioDiscovery competitors and assessment
Company assessmentBroad incumbents
- Illumina: Dominant NGS platform vendor whose short-read sequencing workflows overlap with Bionano's molecular genomics applications and compete for cytogenomics and oncology research budgets.
- Agilent Technologies: Analytical laboratory instruments and genomics solutions provider with overlapping customer base in molecular genomics, cytogenetics, and clinical research labs.
- Revvity (formerly PerkinElmer): Life sciences and diagnostics instruments company; both a Bionano software marketing partner and a broad incumbent in reproductive health and newborn screening workflows where OGM is now positioned.
- Bio-Techne: Supplies reagents, instruments, and assays used in molecular biology and genomics workflows that overlap with Bionano's cytogenomics and cell bioprocessing customers.
Regional players
- Natera: Molecular diagnostics company focused on reproductive health and oncology testing that overlaps with Bionano's genetic disease and oncology applications in the U.S. clinical market.
Emerging players
- NeoGenomics: Clinical oncology genomics laboratory that could either partner with or compete against Bionano Laboratories' OGM data services in hematological malignancy and solid tumor profiling.
- 10x Genomics: Genomics platform company offering linked-read and single-cell solutions that intersect with Bionano's structural variant and cell bioprocessing applications.
- Element Biosciences: Sequencing platform challenger whose lower-cost genomics systems compete for the same research and translational lab capital budgets as Bionano's OGM instruments.
Direct peers
- Pacific Biosciences (PacBio): Long-read sequencing platform that competes directly with OGM in detecting large structural variants and complex genomic rearrangements across research and clinical markets.
- Oxford Nanopore Technologies: Long-read sequencing provider whose platforms are an alternative to OGM for comprehensive structural variant detection and repeat-rich region analysis.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
BioDiscovery social profiles
Digital presenceBioDiscovery financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioDiscovery leadership team
Management profileNumber of profiles
BioDiscovery subsidiaries and ownership
Company hierarchySubsidiaries1 record
BioDiscovery funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioDiscovery M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioDiscovery
What does BioDiscovery do?
BioDiscovery develops scientific software and instrumentation for genetic research and genomic analysis. The company's portfolio includes optical genome mapping systems (Stratys, Saphyr) for structural variant detection, analysis software (VIA, Access, EnFocus) for integrating OGM, NGS, and microarray data, the Ionic nucleic acid purification system using isotachophoresis, and consumables and data services supporting end-to-end genomic workflows.
Is BioDiscovery a public or private company?
BioDiscovery is a public company. It is classified as unknown and is currently operating.
When was BioDiscovery founded?
BioDiscovery was founded in 1997. It employs 11 to 50 people.
Where is BioDiscovery based?
BioDiscovery is headquartered in Ann Arbor, United States, in the North America region.
How does BioDiscovery make money?
Four revenue lines are on record. OGM Hardware Systems are the primary driver. The others are software Licenses and Subscriptions, consumables and Kits and data Services.
Who are BioDiscovery's main competitors?
Broad incumbents on record are Illumina, Agilent Technologies, Revvity (formerly PerkinElmer) and Bio-Techne. Natera is listed as a regional player. Emerging players are NeoGenomics, 10x Genomics and Element Biosciences. Direct peers are Pacific Biosciences (PacBio) and Oxford Nanopore Technologies.
Does BioDiscovery have an API?
No public API is recorded for BioDiscovery.
What industry is BioDiscovery in?
BioDiscovery's product category is Genomic Analysis Software. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAGAJAD, Bioinformatics & Multi-omics Analysis Software. Its NAICS code is 334516 and its SIC code is 3826.